Free Trial
NASDAQ:EGRX

Eagle Pharmaceuticals (EGRX) Stock Price, News & Analysis

Eagle Pharmaceuticals logo
$3.19 0.00 (0.00%)
As of 08/8/2025 12:49 PM Eastern

About Eagle Pharmaceuticals Stock (NASDAQ:EGRX)

Key Stats

Today's Range
$2.55
$3.19
50-Day Range
$1.98
$3.75
52-Week Range
$1.50
$3.87
Volume
3,769 shs
Average Volume
7,183 shs
Market Capitalization
$41.43 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive EGRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Eagle Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

EGRX Stock News Headlines

Eagle Pharmaceuticals, Inc. (EGRX) - Yahoo Finance
EGRX Eagle Pharmaceuticals, Inc. - Seeking Alpha
$100 Trillion “AI Metal” Found in American Ghost Town
Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.
Eagle Pharmaceuticals to Delist from Nasdaq
See More Headlines

EGRX Stock Analysis - Frequently Asked Questions

Eagle Pharmaceuticals' stock was trading at $0.50 on January 1st, 2025. Since then, EGRX stock has increased by 538.0% and is now trading at $3.19.

Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) announced its earnings results on Tuesday, November, 9th. The specialty pharmaceutical company reported $0.56 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.44) by $1.00. The specialty pharmaceutical company had revenue of $39.85 million for the quarter, compared to analysts' expectations of $46.70 million.

Shares of EGRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Eagle Pharmaceuticals investors own include Meta Platforms (META), NVIDIA (NVDA), Tesla (TSLA), Netflix (NFLX), Exxon Mobil (XOM), Advanced Micro Devices (AMD) and JPMorgan Chase & Co. (JPM).

Company Calendar

Last Earnings
11/09/2021
Today
8/09/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:EGRX
CIK
827871
Fax
N/A
Employees
100
Year Founded
2007

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$257.55 million
Price / Sales
0.16
Cash Flow
$7.98 per share
Price / Cash Flow
0.40
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
12,987,000
Free Float
9,234,000
Market Cap
$41.43 million
Optionable
No Data
Beta
0.83

Social Links

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NASDAQ:EGRX) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners